SCORE

39

SGYP: Synergy Pharmaceuticals, Inc. is a Sell


The current rating for SGYP is 39, which is 28% below its historic median rating of 50. This indicates higher risk than normal.


The rating is currently showing a lower than normal reading, suggesting risk levels could be higher than normal and additional caution is advised.